[Science News] KRICT and KRIBB License PROTAC-Based Anticancer Technology to Dong-A ST
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
KRICT and KRIBB have licensed a PROTAC-based anticancer technology to Dong-A ST. This technology is reportedly related to cancer treatment. The terms and implications of the licensing agreement are not specified.